Insights on Clinical Trials

  1. Scaling Success: A Blueprint For Flexible Biometrics Partnerships 2/19/2026

    Learn how a micro-FSP model and integrated biometrics team can scale from specialized support to a full-service solution, ensuring agility and consistency as clinical trial needs evolve.

  2. 4 Core Biomarker-Driven Study Designs In Oncology 2/19/2026

    Modern oncology demands smarter trial designs. Explore how enrichment, stratification, and basket models transform biomarker data into successful, regulatory-ready clinical programs.

  3. Transforming PSP Enrollment To Enhance User Experiences And Optimize Workflows 2/18/2026

    Lengthy enrollment calls burden patients and PSP teams alike. See how a digital-first intake approach cut onboarding time and improved outcomes for everyone involved.

  4. The Value Of Real-World Evidence In Canadian Drug Commercialization 2/18/2026

    Leveraging real-world evidence (RWE) across the product lifecycle enables manufacturers to fill the evidence gap beyond RCTs to help guide local commercial strategic planning and market access strategy.

  5. Digitized Solutions To Increase Visibility And Streamline Communication Between A PSP And Manufacturer 2/18/2026

    When email-based escalation management creates compliance and visibility gaps, a centralized digital solution helps manufacturer and PSP teams act faster and with greater accountability.

  6. Active Versus Passive Shipping Solutions For Clinical Shipments 2/13/2026

    Explore active and passive temperature-controlled shipping solutions and their impact on clinical trial supply, balancing cost, risk, and product integrity.

  7. How Integrated Early Development Is Rewriting Proof-of-Concept 2/9/2026

    How can you move faster from First-in-Human to Proof-of-Concept? Learn how integrating real-time manufacturing and clinical data removes the gaps that stall early development programs.

  8. Why Early CRO Choice Is Critical To Accelerating Delivery Of Your Clinical Program 2/9/2026

    Regulatory readiness for global expansion begins in Phase I. A development partner should design your trial and data collection to anticipate downstream regulatory requirements in your target regions.

  9. Why Clinical Supply Risk Starts With Demand Signals 2/5/2026

    Clinical supply risk often begins long before manufacturing or distribution. Flawed demand signals and enrollment forecasts can quietly create shortages, delays, and costly material waste.

  10. Retention Through Intention — Designing Truly Patient-Centric Trials 2/4/2026

    High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.